Cipla Ltd.

History:
Cipla Ltd. was founded in 1935 by Dr. K.A. Hamied, an Indian scientist and entrepreneur. The company started as a small laboratory in Mumbai, India, and has since grown into a global pharmaceutical company. Cipla has been at the forefront of the fight against HIV/AIDS and has played a key role in making affordable antiretroviral drugs accessible to millions of people in developing countries.

Profile:
Cipla Ltd. is one of the leading pharmaceutical companies in India and is known for its high-quality, affordable generic drugs. The company has a strong focus on research and development and has a team of over 1,600 scientists working on the development of new drugs and technologies. Cipla has a presence in over 80 countries worldwide and operates through subsidiaries, joint ventures, and strategic alliances.

Products:
Cipla Ltd. offers a wide range of pharmaceutical products, including prescription and over-the-counter drugs, active pharmaceutical ingredients (APIs), and veterinary products. Some of the popular products offered by the company include Seroflo (for asthma), Duolin (for respiratory diseases), and Virohep (for hepatitis B). Cipla also offers a range of biosimilars, including monoclonal antibodies and recombinant proteins.

Financials:
As of September 2021, Cipla Ltd. has a market capitalization of over $11 billion. The company has a strong financial track record, and in FY 2020-21, it reported a revenue of INR 18,066 crore (approximately $2.4 billion) and a net profit of INR 2,300 crore (approximately $310 million). The company has consistently been recognized for its financial performance and is listed on both the National Stock Exchange of India and the Bombay Stock Exchange.

Cipla is committed to sustainable and ethical business practices and has received several awards and recognitions for its contributions to the pharmaceutical industry. The company is also actively involved in several social initiatives, including providing education and healthcare services to underserved communities.

Cipla founded as The Chemical, Industrial & Pharmaceutical Laboratories is a major Indian pharmaceutical company, best-known for manufacturing economical anti-AIDS drugs.

Cipla is the world's largest manufacturer of antiretroviral drugs to fight HIV/AIDS, as measured by units produced, distributed and sold.

The customary treatment of AIDS consists of a cocktail of three drugs. Cipla produces an all-in-one pill called Triomune which contains all three substances (Lamivudine, stavudine and Nevirapine), something difficult elsewhere because the three patents are held by different companies.

Corporate Office:

Address:
Cipla Ltd.
Mumbai Central
Mumbai 400 008
India

Telephone : 91 22 2308 2891/91 22 2309 5521
Fax: 91 22 2307 0013/91 22 2307 0393

Web : http://www.cipla.com/